NERVGEN PHARMA CORP (NGEN) Institutional Shareholders

NERVGEN PHARMA CORP (NGEN) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $24.81M in NGEN holdings during the latest filing period.

Empery Asset Management, Lp is currently the largest disclosed institutional shareholder of NGEN tracked by InsiderSet, reporting ownership valued at approximately $8.24M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $8.20M, representing an estimated loss of -0.49% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 82% of the total disclosed NGEN value among the investors covered in this analysis. Major shareholders include Empery Asset Management, Lp, Rock Springs Capital Management Lp, Dafna Capital Management Llc, and several other long-term asset managers with concentrated positions in NERVGEN PHARMA CORP (NGEN).

This page ranks the largest institutional NGEN shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

60

Total Reported Value

$24.81M

Largest Holder

Empery Asset Management, Lp

Largest Position

$8.24M

Insider Transactions (90d)

0

Latest Filing Quarter

Q2 2026

New Institutional Positions

64

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Empery Asset Management, Lp9.53%4,000,000$8,240,000$8,200,000-$40,000-0.49%
Rock Springs Capital Management Lp0.12%1,208,231$2,488,956$2,476,874-$12,082-0.49%
Dafna Capital Management Llc0.41%1,050,000$2,163,000$2,152,500-$10,500-0.49%
Ghisallo Capital Management Llc0.04%1,000,000$2,060,000$2,050,000-$10,000-0.49%
Armistice Capital, Llc0.04%678,000$1,396,680$1,389,900-$6,780-0.49%
Lmr Partners Llp0.01%600,000$1,236,000$1,230,000-$6,000-0.49%
Marshall Wace, Llp0.00%435,962$898,081$893,722-$4,359-0.49%
Ubs Group Ag0.00%379,726$782,236$778,438-$3,798-0.49%
Stonepine Capital Management, Llc0.43%271,678$559,657$556,940-$2,717-0.49%
Jane Street Group, Llc0.00%270,750$557,746$555,038-$2,709-0.49%
Woodline Partners Lp0.00%250,500$516,030$513,525-$2,505-0.49%
Pfg Investments, Llc0.02%217,500$448,050$445,875-$2,175-0.49%
Bank Of America Corp0.00%186,200$383,572$381,710-$1,862-0.49%
Royal Bank Of Canada0.00%176,075$363,000$360,954-$2,046-0.56%
Bank Of Montreal0.00%78,394$284,382$160,708-$123,674-43.49%
Quadrature Capital Ltd0.00%134,518$277,107$275,762-$1,345-0.49%
Integrated Wealth Concepts Llc0.00%74,215$152,883$152,141-$742-0.49%
Captrust Financial Advisors0.00%64,423$132,711$132,067-$644-0.49%
Geode Capital Management, Llc0.00%58,040$119,562$118,982-$580-0.49%
Osaic Holdings, Inc.0.00%51,093$105,250$104,741-$509-0.48%
Hrt Financial Lp0.00%43,858$90,000$89,909-$91-0.10%
Axq Capital, Lp0.01%43,099$88,784$88,353-$431-0.49%
Liberty Wealth Management Llc0.01%22,000$82,940$45,100-$37,840-45.62%
Millennium Management Llc0.00%39,740$81,864$81,467-$397-0.48%
Great Valley Advisor Group, Inc.0.00%35,500$73,130$72,775-$355-0.49%
Virtu Financial Llc0.00%34,589$71,000$70,907-$93-0.13%
Commonwealth Equity Services, Llc0.00%33,000$67,980$67,650-$330-0.49%
Mckinley Carter Wealth Services, Inc.0.00%32,653$67,266$66,939-$327-0.49%
Traynor Capital Management, Inc.0.00%31,500$64,890$64,575-$315-0.49%
Cetera Investment Advisers0.00%31,400$64,684$64,370-$314-0.49%
Patriot Financial Group Insurance Agency, Llc0.01%28,500$58,710$58,425-$285-0.49%
Lpl Financial Llc0.00%26,710$55,023$54,755-$268-0.49%
Almanack Investment Partners, Llc.0.01%25,750$53,045$52,787-$258-0.49%
Busey Bank0.00%25,000$51,500$51,250-$250-0.49%
Sprott Inc.0.00%25,000$51,500$51,250-$250-0.49%
Td Waterhouse Canada Inc.0.00%23,800$49,812$48,790-$1,022-2.05%
Wells Fargo & Company/Mn0.00%22,000$45,320$45,100-$220-0.49%
Envestnet Asset Management Inc0.00%20,000$41,200$41,000-$200-0.49%
Arax Advisory Partners0.00%19,727$40,638$40,440-$198-0.49%
Goldman Sachs Group Inc0.00%19,623$40,423$40,227-$196-0.48%
Mariner, Llc0.00%17,875$36,823$36,644-$179-0.49%
Moors & Cabot, Inc.0.00%17,036$35,094$34,924-$170-0.48%
Price T Rowe Associates Inc0.00%15,504$32,000$31,783-$217-0.68%
Wealth Enhancement Advisory Services, Llc0.00%16,462$30,949$33,747+$2,798+9.04%
Jpmorgan Chase & Co0.00%14,714$28,840$30,164+$1,324+4.59%
Morgan Stanley0.00%12,939$26,654$26,525-$129-0.48%
Scotia Capital Inc.0.00%12,740$26,340$26,117-$223-0.85%
Cibc World Market Inc.0.00%10,960$22,578$22,468-$110-0.49%
Ashton Thomas Private Wealth, Llc0.00%10,700$22,042$21,935-$107-0.49%
Revisor Wealth Management Llc0.01%10,600$21,836$21,730-$106-0.49%
Showing 50 of 60

Frequently asked questions about NGEN

  • Who owns the most NGEN stock?

    The largest holders of NGEN are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for NERVGEN PHARMA CORP (NGEN).

  • Is NGEN widely held by superinvestors?

    Many widely followed stocks like NGEN appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly NGEN is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.